Xiaozhou Hu

Xiaozhou Hu

Auto-generated profile, based on publicly available information

Xiaozhou Hu

Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
Can KüçükCan Küçük
Can Küçük
BJBei Jiang
Bei Jiang
XHXiaozhou Hu
Xiaozhou Hu
WZWenyan Zhang
Wenyan Zhang
JCJohn K. C. Chan
John K. C. Chan
WCWing (John) C Chan
Wing (John) C Chan
Lymphomas arising from NK or γδ-T cells are very aggressive diseases and little is known regarding their pathogenesis. Here we report frequent activating mutations of STAT3 and STAT5B in NK/T-cell lymphomas (n=51), γδ-T-cell lymphomas (n=43) and their cell lines (n=9) through next generation and/or Sanger sequencing. STAT5B N642H is particularly frequent in all forms of γδ-T-cell lymphomas. STAT3 and STAT5B mutations are associated with increased phosphorylated protein and a growth advantage to transduced cell lines or normal NK cells. Growth-promoting activity of the mutants can be partially inhibited by a JAK1/2 inhibitor. Molecular modelling and surface plasmon resonance measurements of the N642H mutant indicate a marked increase in binding affinity of the phosphotyrosine-Y699 with the mutant histidine. This is associated with the prolonged persistence of the mutant phosphoSTAT5B and marked increase of binding to target sites. Our findings suggest that JAK-STAT pathway inhibition may represent a therapeutic strategy.

21 November 2013 in Blood
Verified
Journal Article
Open access
PDF file
APAnamarija M. Perry
Anamarija M. Perry
RWRoger A. Warnke
Roger A. Warnke
QHQinglong Hu
Qinglong Hu
PGPhilippe Gaulard
Philippe Gaulard
CCChristiane Copie-Bergman
Christiane Copie-Bergman
WCWing C. Chan
Wing C. Chan
Key Points: Ten cases of an indolent T-cell lymphoproliferative disease of the gastrointestinal tract are reported. It is important to recognize this condition because it can be mistaken for aggressive T-cell lymphoma, which may lead to unnecessary therapy.

5 December 2011 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
Can KüçükCan Küçük
Can Küçük
JIJaveed Iqbal
Javeed Iqbal
XHXiaozhou Hu
Xiaozhou Hu
PGPhillip Gaulard
Phillip Gaulard
LLLaurence De Leval
Laurence De Leval
WCWing C. Chan
Wing C. Chan
Natural killer cell lymphoma (NKCL) constitutes a rare and aggressive form of non-Hodgkin lymphoma, and there is little insight into its pathogenesis. Here we show that PRDM1 is a tumor suppressor gene in NKCLs that is inactivated by a combination of monoallelic deletion and promoter CpG island hypermethylation. We observed monoallelic deletion of PRDM1 loci in 8 of 18 (44%) NKCL cases. The other allele showed significant promoter methylation in 12 of 17 (71%) cases. In support of its role as a tumor suppressor gene, the reconstitution of PRDM1 in PRDM1-null NK cell lines led to G2/M cell cycle arrest, increased apoptosis, and a strong negative selection pressure with progressive elimination of PRDM1-expressing cells, which was enhanced when IL-2 concentration is limiting. We observed a progressive increase in PRDM1 expression—in particular, PRDM1 α—in normal NK cells in response to IL-2 and in normal NK cells activated with an engineered NK cell target, K562-Cl9-mb21, suggesting its role in NK cell homeostasis. In support of this role, knockdown of PRDM1 by shRNA in normal NK cells resulted in the positive selection of these cells. We identified MYC and 4-1BBL as targets of PRDM1 in NK cells. Disruption of homeostatic control by PRDM1 may be an important pathogenetic mechanism for NKCL.

31 March 2015 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
Can KüçükCan Küçük
Can Küçük
XHXiaozhou Hu
Xiaozhou Hu
BJBei Jiang
Bei Jiang
DKDavid Klinkebiel
David Klinkebiel
HGHuimin Geng
Huimin Geng
WCWing (John) C Chan
Wing (John) C Chan
Purpose: To identify tumor suppressor genes epigenetically silenced by promoter hypermethylation in extranodal natural killer cell lymphoma (NKCL). Experimental Design: Promoter methylation was analyzed with global and locus-specific methylation assays in NKCL cases and NK cell lines. Gene expression profiles were used to identify genes for which aberrant promoter methylation was associated with transcriptional silencing. Selected DNA methylations were validated by RRBS, pyrosequencing, or q-MSP. Decitabine treatment was performed to evaluate reactivation of methylated genes. The tumor suppressor effect of silenced genes was evaluated functionally by reintroducing them into NK cell lines. Results: We observed significant promoter hypermethylation in most NKCL samples compared with normal NK cells. Correlation of global promoter methylation with gene expression profiles identified 95 genes with strong evidence for being silenced because of promoter methylation, including BCL2L11 (BIM), DAPK1, PTPN6 (SHP1), TET2, SOCS6, and ASNS. Known tumor suppressor genes were significantly overrepresented in this set of genes. Decitabine treatment of NK cell lines was associated with reexpression of all 10 selected methylated and silenced genes. Ectopic expression of frequently silenced BIM in two BIM-nonexpressing NK cell lines led to increased apoptosis and eventual elimination of BIM-transduced cells. It also sensitized these cell lines to chemotherapy-induced apoptosis. Similarly, reintroduction of SOCS6 significantly inhibited growth in SOCS6-nonexpressing NK cell lines. NK cell lines lacking ASNS expression showed increased sensitivity to treatment with l-asparaginase. Reintroduction of ASNS reduced drug sensitivity. Conclusion: Promoter region hypermethylation is frequent in NKCL, and aberrantly methylated genes are pathologically and clinically significant. Clin Cancer Res; 21(7); 1699–711. ©2015 AACR.

19 September 2013 in Blood
Verified
Journal Article
Closed access
PDF file
CLCuiling Liu
Cuiling Liu
JIJaveed Iqbal
Javeed Iqbal
JTJulie Teruya-Feldstein
Julie Teruya-Feldstein
YSYulei Shen
Yulei Shen
MDMagdalena Julia Dabrowska
Magdalena Julia Dabrowska
WCWing C. Chan
Wing C. Chan
Key Points: Anaplastic large-cell lymphoma has a unique miRNA signature. The miR-17∼92 is an important downstream effector of ALK oncogenic pathway.

1 January 2013 in The American Journal of Pathology
Verified
Journal Article
Open access
Can KüçükCan Küçük
Can Küçük
XHXiaozhou Hu
Xiaozhou Hu
JIJaveed Iqbal
Javeed Iqbal
PGPhilippe Gaulard
Philippe Gaulard
DKDavid Klinkebiel
David Klinkebiel
WCWing C. Chan
Wing C. Chan
HACE1 is an E3 ubiquitin ligase located in 6q21, the genomic region frequently deleted in natural killer (NK) cell malignancies. Here, we report HACE1 as a candidate tumor suppressor gene silenced through a combination of deletion and cytosine phosphate guanine island hypermethylation. We detected deletion of HACE1 in malignant NK cell lines (6 of 9, 67%) and primary biopsies (5 of 15, 33%) by quantitative PCR, with most of the specimen showing cytosine phosphate guanine island hypermethylation in the remaining allele, leading to low mRNA transcription. The ectopic expression of HACE1 in an HACE1-null NK cell line led to apoptosis and G2/M cell cycle arrest. Moreover, HACE1 expression was up-regulated in IL-2-activated normal NK cells and NK cells cocultured with an engineered NK cell target, K562 Clone 9.mbIL21, suggesting its role in the regulation of NK cell homeostasis. In conclusion, HACE1 is another potent tumor suppressor gene located within the 6q21 region, and loss of function of multiple tumor suppressor genes within 6q21 may be a critical determinant of NK cell lymphomagenesis.